American Well Corporation (NYSE:AMWL) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET
Company Participants
Sue Dooley - Head of IR
Ido Schoenberg - Chairman and CEO
Bob Shepardson - CFO
Conference Call Participants
Craig Hettenbach - Morgan Stanley
Jack Wallace - Guggenheim Securities
Stan Bernstein - Wells Fargo Securities
Glen Santangelo - Jefferies
Charles Rhyee - TD Cowen
Alan Lutz - Bank of America Merrill Lynch
Operator
Good afternoon. My name is David and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Amwell Q2 to 2023 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there'll be a question-and-answer session. [Operator Instructions]. I would now like to hand the call over to Sue Dooley, Head of Investor Relations at Amwell, you may begin.
Sue Dooley
Hello, everyone, welcome to Amwell’s conference call to discuss our second quarter of 2023. This is Sue Dooley of Amwell Investor Relations. Joining me today are Amwell’s Chairman and CEO, Ido Schoenberg and Bob Shepardson, our CFO. Earlier today we distributed a press release detailing our announcement. This release is posted on our investors.amwell.com and is also available from normal news sources. This conference call is being webcast live on the IR page of our website where a replay will be archived.
Before we begin our prepared remarks, I would like to take this opportunity to remind you that, during the course of this call, we will make forward-looking statements regarding projected operating results and anticipated market opportunities. This forward-looking information is subject to the risks and uncertainties described in our filings with the SEC and actual results or events may differ materially. Except as required by law, we undertake no obligation to update or revise these statements.
On this call, we will refer to both GAAP and non-GAAP financial measures. A reconciliation of our GAAP to non-GAAP financial measures is provided in our posted earnings release. With that, I would like to turn the call over to Ido.
Ido Schoenberg
Thank you, Sue. And hello, everyone. The second quarter of 2023 was another solid quarter for our company. With most of Converge development behind us we made progress as we continue migrating health systems and payer migrations are underway. I'm also pleased to announce we added to our list of strategic clients of Converge further validated our approach to the market. We are also putting important pieces in place is we work to reaccelerate our bookings momentum. I would like to go into some more details on the highlights of Q2 before discussing what you're seeing in the market. Then, we'll cover our financial results.